Flow Traders U.S.’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Flow Traders U.S.’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,359	Closed	–	–	1348
2025 Q1	$0	Sell	16,359 -9,035	-36%	-$659	﹤0.01%	1418
2024 Q4	$3K	Buy	25,394 +13,051	+106%	+$666	﹤0.01%	925
2024 Q3	$1K	Sell	12,343 -2,903	-19%	-$260	﹤0.01%	837
2024 Q2	$1K	Buy	+15,246	New	+$1.59K	﹤0.01%	826
2023 Q3	–	Sell	-12,524	Closed	-$2K	–	1224
2023 Q2	$2K	Buy	12,524 +1,092	+10%	+$192	﹤0.01%	777
2023 Q1	$2K	Buy	+11,432	New	+$1.63K	﹤0.01%	799

Flow Traders U.S.'s NKGNW Position: Q2 2025 in Review

Flow Traders U.S. sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q2 2025, closing a stake of 16,359 shares.

Flow Traders U.S. first reported a position in NKGNW in Q1 2023 and held it in 6 quarters. The position peaked at $3K in Q4 2024. 0 funds tracked by Wall St. Rank hold NKGNW as of Q2 2025.

Flow Traders U.S. reported no remaining NKGen Biotech, Inc. Warrants position as of Q2 2025 after selling out during the quarter.
Flow Traders U.S. sold 16,359 NKGen Biotech, Inc. Warrants shares in Q2 2025.
Flow Traders U.S. first reported a position in NKGen Biotech, Inc. Warrants in Q1 2023 and held it in 6 quarters.
Flow Traders U.S.'s NKGen Biotech, Inc. Warrants position peaked at $3K in Q4 2024.
0 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q2 2025.

Based on Flow Traders U.S.'s 13F filing for Q2 2025, filed 13 Aug 2025.